In the news

Mitchell Salloum became the first patient to receive a WATCHMAN™ implant in Wyoming. The Boston Scientific WATCHMAN implant is placed into a patient’s heart in a one-time procedure that may reduce stroke risk for a lifetime in patients with irregular heartbeats.

Many Fortune 500 companies have long-standing, well-oiled programs that often funnel into post-grad development and leadership programs or full-time jobs. For Lauren Nakamura, her marketing internship at Boston Scientific changed the course of her career and gave her confidence and reassurance that she was joining a workplace culture that prioritized work-life integration.

The MODULAR ATP clinical trial has begun to enroll patients to evaluate the safety, performance and effectiveness of Boston Scientific’s mCRM modular therapy system, which includes the Emblem MRI S-ICD and the Empower MPS leadless pacemaker.

*The EMPOWER MPS is an investigational device and limited by U.S. law to investigational use only. It is not available for sale. Some device references are for informational purposes only and are pending CE Mark. Not available in the European Economic Area.

The global medical device manufacturer has maintained operational continuity throughout the pandemic, using clear processes and procedures mixed with a healthy dose of care.

Our innovative TheraSphere™ technology, which increases HCC liver cancer survival rates, may be an effective treatment for other tumors.